These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34782445)

  • 21. Use of thermal desorption GC-MS to characterize packaging materials for potential extractables.
    Zweiben C; Shaw AJ
    PDA J Pharm Sci Technol; 2009; 63(4):353-9. PubMed ID: 20088248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Best practices for extractables and leachables in orally inhaled and nasal drug products: an overview of the PQRI recommendations.
    Norwood DL; Paskiet D; Ruberto M; Feinberg T; Schroeder A; Poochikian G; Wang Q; Deng TJ; DeGrazio F; Munos MK; Nagao LM
    Pharm Res; 2008 Apr; 25(4):727-39. PubMed ID: 18183477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis and evaluation of single-use bag extractables for validation in biopharmaceutical applications.
    Pahl I; Dorey S; Barbaroux M; Lagrange B; Frankl H
    PDA J Pharm Sci Technol; 2014; 68(5):456-71. PubMed ID: 25336417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simulated Leaching (Migration) Study for a Model Container-Closure System Applicable to Parenteral and Ophthalmic Drug Products.
    Jenke D; Egert T; Hendricker A; Castner J; Feinberg T; Houston C; Hunt DG; Lynch M; Nicholas K; Norwood DL; Paskiet D; Ruberto M; Smith EJ; Holcomb F; Markovic I
    PDA J Pharm Sci Technol; 2017; 71(2):68-87. PubMed ID: 27974627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Use of TOC Reconciliation as a Means of Establishing the Degree to Which Chromatographic Screening of Plastic Material Extracts for Organic Extractables Is Complete.
    Jenke D; Couch TR; Robinson SJ; Volz TJ; Colton RH
    PDA J Pharm Sci Technol; 2014; 68(3):256-70. PubMed ID: 25188347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives on the PQRI Extractables and Leachables "Safety Thresholds and Best Practices" Recommendations for Inhalation Drug Products.
    Norwood DL; Nagao LM; Stults CL
    PDA J Pharm Sci Technol; 2013; 67(5):413-29. PubMed ID: 24084658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP).
    Paskiet D; Jenke D; Ball D; Houston C; Norwood DL; Markovic I
    PDA J Pharm Sci Technol; 2013; 67(5):430-47. PubMed ID: 24084659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring three-dimensional space of extractables and leachables in volatility, hydrophobicity, and molecular weight and assessment of roles of gas and liquid chromatographic methods in their comprehensive analysis.
    Li BJ
    J Pharm Biomed Anal; 2023 Jan; 223():115142. PubMed ID: 36371915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Framework for sensitization assessment of extractables and leachables in pharmaceuticals.
    Parris P; Whelan G; Burild A; Whritenour J; Bruen U; Bercu J; Callis C; Graham J; Johann E; Griffin T; Kohan M; Martin EA; Masuda-Herrera M; Stanard B; Tien E; Cruz M; Nagao L
    Crit Rev Toxicol; 2022 Feb; 52(2):125-138. PubMed ID: 35703156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extractables and leachables considerations for prefilled syringes.
    Jenke DR
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1591-600. PubMed ID: 24955780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Principles for Management of Extractables and Leachables in Ophthalmic Drug Products.
    Houston CT; Rodrigues AD; Smith BB; Wang T; Richardson M
    PDA J Pharm Sci Technol; 2022; 76(3):278-294. PubMed ID: 35169039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extractables characterization for five materials of construction representative of packaging systems used for parenteral and ophthalmic drug products.
    Jenke D; Castner J; Egert T; Feinberg T; Hendricker A; Houston C; Hunt DG; Lynch M; Shaw A; Nicholas K; Norwood DL; Paskiet D; Ruberto M; Smith EJ; Holcomb F
    PDA J Pharm Sci Technol; 2013; 67(5):448-511. PubMed ID: 24084660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of extractables by liquid chromatography-high resolution mass spectrometry: A case study to understand the extraction profile of different disposable syringes.
    Kurmi M; Prasad S; Panduranga NS; Jayaraman K; Bhutani H
    J Pharm Biomed Anal; 2020 Nov; 191():113602. PubMed ID: 33010603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Method Utilizing Ultra-High Performance Liquid Chromatography with Ultraviolet and Mass Spectrometric Detection for the Analysis of Material Extracts Produced during a Controlled Extraction Study.
    Zdravkovic SA; Bruss MD; Piccoli RF; Wood DM
    PDA J Pharm Sci Technol; 2014; 68(5):504-26. PubMed ID: 25336421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supercritical Fluid Extraction Combined with Ultrahigh Performance Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry for Determination of Extractables to Evaluate Compatibility of Drugs with Rubber Closures.
    Sun X; Zheng X; Tang Y; Debrah AA; Du Z
    AAPS PharmSciTech; 2021 Jan; 22(1):50. PubMed ID: 33458791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated Solid Phase Extraction (SPE) LC/NMR Applied to the Structural Analysis of Extractable Compounds from a Pharmaceutical Packaging Material of Construction.
    Norwood DL; Mullis JO; Davis M; Pennino S; Egert T; Gonnella NC
    PDA J Pharm Sci Technol; 2013; 67(3):267-87. PubMed ID: 23752753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of leachables observed in the size exclusion chromatograms of a low concentration product stored in prefilled syringes.
    Valente JJ; Peddicord MB; Rinaldi FA; Kelly KA; Bolgar MS
    J Pharm Biomed Anal; 2017 May; 139():133-142. PubMed ID: 28279928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of nonvolatile organic compounds (NVOCs) in biopharmaceuticals through non-target analysis and quantification using complexation-precipitation extraction.
    Luo F; Hao M; Zhang L; Xie Y; Hou W; Wang H; Zhang Z
    J Chromatogr A; 2024 Jan; 1713():464540. PubMed ID: 38039624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 3-Considering Errors of Implementation and the Use of a Database to Judge and Promote Good Science and Efficient Practices.
    Jenke D
    PDA J Pharm Sci Technol; 2020; 74(1):134-146. PubMed ID: 31209166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of an Adduct Impurity of an Active Pharmaceutical Ingredient and a Leachable in an Ophthalmic Drug Product Using LC-QTOF.
    Gollapalli R; Singh G; Blinder A; Brittin J; Sengupta A; Mondal B; Patel M; Pati B; Lee J; Ghode A; Kote M
    J Pharm Sci; 2019 Oct; 108(10):3187-3193. PubMed ID: 31226425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.